8 Apr 2025 • Tracking over 413,000 adults has found that sarcopenia—characterized by low muscle strength, mass, and gait speed—is a key predictor of progression along the cardiometabolic disease (CMD) trajectory, including coronary heart disease, stroke, and diabetes.

Individuals with confirmed or severe sarcopenia faced a 42% higher risk of developing a single CMD and were more than twice as likely to die (HR 2.08) compared to those without sarcopenia.

They were also significantly more likely to progress from single CMD to multimorbidity (HR 1.69) and death (HR 2.05).

Source: BMC Public Health | Read Full Story